González-Villanueva L, Gutiérrez-Quintana Y, Naranjo-Medina M, Cepero-Cuervo Z, Reyes-Molina K, Rodríguez-Montero MC, Contreras-Torres DE, Lazo-Patterson MM, Villegas-Cabrera A, Teruel-Sera JC, Chacón-Ricardo O

Language: Spanish
References: 0
Page: 37-44
PDF size: 333.38 Kb.

ABSTRACT

A preliminary evaluation of production losses was carried out in several scenarios of the Aseptic Processing and Packaging Plant of Finlay Vaccine Institute, Havana, Cuba. The evaluation covered the areas of formulation, filling, labeling and packaging, during the period 2011-2015, with the purpose of constituting a useful tool that would influence the production costs and improve the efficiency of the company. The results show that the formulation stage presents a higher average loss due to wastage (6.99%), mainly contributed by the vaccines DTP-vax^® and VA-MENGOC-BC^®; followed by the filling stage with an average loss of 4%. The losses for the rest of the stages ranged between 0.2% and 1.57%. The general cost of the losses of this period was 8,949,871.79 Cuban pesos, contributed by vax-SPIRAL^®, vax-TyVi^®, vax-TET^® and VA-MENGOC-BC^® vaccines. It was observed that, except for vax-TET-5)^® (presentation of 20 doses), due to problems faced with the volume of the bulbs, the losses of the year 2016 were below the established percentage. Finally, a trend analysis was made of the total losses and by presentation, in the period 2011 to 2016, showing that in 2015 the highest quantity of vaccine losses was obtained, with a higher incidence in the presentation of 20 doses.